Oxford Finance Closes $30MM Selux Diagnostics Credit Facility

Oxford Finance closed a $30 million senior secured term loan with Selux Diagnostic, a Boston-based medical device company focused on personalized diagnostics to combat superbug infections and fight antibiotic resistance.

June 2, 2022 Christopher A. Herr | Oxford Finance | Selux Diagnostic | Steve Lufkin Rita Garwood

Oxford Finance Provides $250MM in Debt Financing to Silk Road Medical

Silk Road Medical, a company focused on reducing the risk of stroke, entered into a five-year loan arrangement with Oxford Finance comprising up to a $200 million term loan and up to a $50 million revolving line of credit.

June 1, 2022 Armentum Partners | Lucas Buchanan | Oxford Finance | Silk Road Medical Ian Koplin

Oxford Finance Provides $100MM Loan Facility to Pliant Therapeutics

Pliant Therapeutics, a clinical stage biotechnology company, entered into a loan facility agreement with Oxford Finance for up to $100 million of non-dilutive financing.

May 6, 2022 Keith Cummings | Oxford Finance | Pliant Therapeutics Ian Koplin

Oxford Finance Provides $660MM Senior Credit Facility to Specialty Dental Brands

Oxford Finance closed a $660 million senior credit facility for Specialty Dental Brands, a dental services organization focused on pediatric dentistry, orthodontics and oral surgery.

March 25, 2022 Oxford Finance | Specialty Dental Brands Ian Koplin

Oxford Finance Provides $150MM Loan Facility to Lexicon Pharmaceuticals

Lexicon Pharmaceuticals entered into a loan facility with Oxford Finance that provides up to $150 million in borrowing capacity designed primarily to support commercial preparations and the potential launch of sotagliflozin for heart failure.

March 21, 2022 Jeffrey L. Wade | Lexicon Pharmaceuticals | Oxford Finance Ian Koplin

Clifford Chance Advises Oxford Finance on $400MM Senior Notes Offering

Clifford Chance advised on the issuance of $400 million senior unsecured notes offering by Oxford Finance and its wholly-owned subsidiary and co-issuer, Oxford Finance Co-Issuer II.

February 28, 2022 Avrohom Gelber | Clifford Chance | Gary Brooks | Hyde Kwan | Jarek Peterson | Jason Parsont | Oxford Finance | Oxford Finance Co-Issuer II | Paul Koppel | Rick Thoben | Thomas Koh Ian Koplin

Gandhi Joins Oxford Finance’s Senior Lending Platform as Senior Director

Rohit Gandhi, a seasoned investment professional, joined Oxford Finance, a specialty finance firm providing senior debt to life sciences and healthcare services companies worldwide, as a senior director.

February 24, 2022 Christopher Herr | Oxford Finance | Rohit Gandhi Ian Koplin

Oxford Provides $50MM Credit Facility to OncoResponse

Oxford Finance closed a $50 million senior secured term loan with OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of elite cancer responders.

February 16, 2022 Chris Russell | Christopher A. Herr | OncoResponse | Oxford Finance Ian Koplin

Oxford Finance Provides $45MM Senior Secured Loan Facility to CENTOGENE

Oxford Finance provided a $45 million senior secured loan facility to CENTOGENE, a commercial-stage company focused on generating data-driven insights to diagnose, understand and treat rare diseases.

February 1, 2022 Careventures | CENTOGENE | Christopher A. Herr | DPE Deutsche Private Equity | Kim Stratton | Moelis & Company | Oxford Finance | René Just | TVM Capital Life Science Ian Koplin

Oxford Finance Provides $50MM Credit Facility to Kezar Life Sciences

Oxford Finance closed a $50 million senior secured term loan for Kezar Life Sciences, a clinical-stage biotechnology company discovering and developing treatments for immune-mediated and oncologic disorders.

November 11, 2021 Christopher A. Herr | Kezar Life Sciences | Marc Belsky | Oxford Finance Ian Koplin